pubrio
NEOK Bio

NEOK Bio

· Biotechnology

Pharmaceuticals

Biotechnology

Healthcare

NEOK Bio is dedicated to advancing cancer treatment through cutting-edge innovation in antibody drug conjugates (ADCs). Partnering with ABL Bio, a leader in antibody engineering, NEOK is developing bispecific ADCs to improve patient outcomes. Our approach aims to overcome limitations of conventional ADCs with a dual-targeting strategy, offering potential for improved safety and efficacy in treating solid tumor cancers.

Company Insights
Company Overview

2025

Founded

Biotechnology

Industry

-

Location

618,915,723

Ranking

0 employees

Size

Similar Companies
Similiar Companies

Get full access to view complete information

Frequently Asked Questions Regarding NEOK Bio

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

Start Journey Image
pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

© 2026 Pubrio. All rights reserved.